These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24939586)

  • 21. Two cases of Noonan syndrome with severe respiratory and gastroenteral involvement and the SOS1 mutation F623I.
    Fabretto A; Kutsche K; Harmsen MB; Demarini S; Gasparini P; Fertz MC; Zenker M
    Eur J Med Genet; 2010; 53(5):322-4. PubMed ID: 20673819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.
    Aoki Y; Niihori T; Banjo T; Okamoto N; Mizuno S; Kurosawa K; Ogata T; Takada F; Yano M; Ando T; Hoshika T; Barnett C; Ohashi H; Kawame H; Hasegawa T; Okutani T; Nagashima T; Hasegawa S; Funayama R; Nagashima T; Nakayama K; Inoue S; Watanabe Y; Ogura T; Matsubara Y
    Am J Hum Genet; 2013 Jul; 93(1):173-80. PubMed ID: 23791108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair.
    Gripp KW; Aldinger KA; Bennett JT; Baker L; Tusi J; Powell-Hamilton N; Stabley D; Sol-Church K; Timms AE; Dobyns WB
    Am J Med Genet A; 2016 Sep; 170(9):2237-47. PubMed ID: 27264673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
    Roberts AE; Araki T; Swanson KD; Montgomery KT; Schiripo TA; Joshi VA; Li L; Yassin Y; Tamburino AM; Neel BG; Kucherlapati RS
    Nat Genet; 2007 Jan; 39(1):70-4. PubMed ID: 17143285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype.
    Carta C; Pantaleoni F; Bocchinfuso G; Stella L; Vasta I; Sarkozy A; Digilio C; Palleschi A; Pizzuti A; Grammatico P; Zampino G; Dallapiccola B; Gelb BD; Tartaglia M
    Am J Hum Genet; 2006 Jul; 79(1):129-35. PubMed ID: 16773572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
    Ekvall S; Sjörs K; Jonzon A; Vihinen M; Annerén G; Bondeson ML
    Am J Med Genet A; 2014 Mar; 164A(3):579-87. PubMed ID: 24357598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation.
    Wu X; Simpson J; Hong JH; Kim KH; Thavarajah NK; Backx PH; Neel BG; Araki T
    J Clin Invest; 2011 Mar; 121(3):1009-25. PubMed ID: 21339642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome–associated Sos1 mutation.
    Chen PC; Wakimoto H; Conner D; Araki T; Yuan T; Roberts A; Seidman C; Bronson R; Neel B; Seidman JG; Kucherlapati R
    J Clin Invest; 2010 Dec; 120(12):4353-65. PubMed ID: 21041952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.
    Capri Y; Flex E; Krumbach OHF; Carpentieri G; Cecchetti S; Lißewski C; Rezaei Adariani S; Schanze D; Brinkmann J; Piard J; Pantaleoni F; Lepri FR; Goh ES; Chong K; Stieglitz E; Meyer J; Kuechler A; Bramswig NC; Sacharow S; Strullu M; Vial Y; Vignal C; Kensah G; Cuturilo G; Kazemein Jasemi NS; Dvorsky R; Monaghan KG; Vincent LM; Cavé H; Verloes A; Ahmadian MR; Tartaglia M; Zenker M
    Am J Hum Genet; 2019 Jun; 104(6):1223-1232. PubMed ID: 31130282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical variability in a Noonan syndrome family with a new PTPN11 gene mutation.
    Bertola DR; Pereira AC; de Oliveira PS; Kim CA; Krieger JE
    Am J Med Genet A; 2004 Nov; 130A(4):378-83. PubMed ID: 15384080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation.
    Kouz K; Lissewski C; Spranger S; Mitter D; Riess A; Lopez-Gonzalez V; Lüttgen S; Aydin H; von Deimling F; Evers C; Hahn A; Hempel M; Issa U; Kahlert AK; Lieb A; Villavicencio-Lorini P; Ballesta-Martinez MJ; Nampoothiri S; Ovens-Raeder A; Puchmajerová A; Satanovskij R; Seidel H; Unkelbach S; Zabel B; Kutsche K; Zenker M
    Genet Med; 2016 Dec; 18(12):1226-1234. PubMed ID: 27101134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.
    Tartaglia M; Pennacchio LA; Zhao C; Yadav KK; Fodale V; Sarkozy A; Pandit B; Oishi K; Martinelli S; Schackwitz W; Ustaszewska A; Martin J; Bristow J; Carta C; Lepri F; Neri C; Vasta I; Gibson K; Curry CJ; Siguero JP; Digilio MC; Zampino G; Dallapiccola B; Bar-Sagi D; Gelb BD
    Nat Genet; 2007 Jan; 39(1):75-9. PubMed ID: 17143282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noonan syndrome, the SOS1 gene and embryonal rhabdomyosarcoma.
    Jongmans MC; Hoogerbrugge PM; Hilkens L; Flucke U; van der Burgt I; Noordam K; Ruiterkamp-Versteeg M; Yntema HG; Nillesen WM; Ligtenberg MJ; van Kessel AG; Kuiper RP; Hoogerbrugge N
    Genes Chromosomes Cancer; 2010 Jul; 49(7):635-41. PubMed ID: 20461756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The novel RAF1 mutation p.(Gly361Ala) located outside the kinase domain of the CR3 region in two patients with Noonan syndrome, including one with a rare brain tumor.
    Harms FL; Alawi M; Amor DJ; Tan TY; Cuturilo G; Lissewski C; Brinkmann J; Schanze D; Kutsche K; Zenker M
    Am J Med Genet A; 2018 Feb; 176(2):470-476. PubMed ID: 29271604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noonan syndrome-like phenotype associated with an ERF frameshift variant.
    Hirano Y; Kuroda Y; Enomoto Y; Naruto T; Muroya K; Kurosawa K
    Am J Med Genet A; 2024 Sep; 194(9):e63652. PubMed ID: 38741564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline KRAS mutations cause Noonan syndrome.
    Schubbert S; Zenker M; Rowe SL; Böll S; Klein C; Bollag G; van der Burgt I; Musante L; Kalscheuer V; Wehner LE; Nguyen H; West B; Zhang KY; Sistermans E; Rauch A; Niemeyer CM; Shannon K; Kratz CP
    Nat Genet; 2006 Mar; 38(3):331-6. PubMed ID: 16474405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further evidence of the importance of RIT1 in Noonan syndrome.
    Bertola DR; Yamamoto GL; Almeida TF; Buscarilli M; Jorge AA; Malaquias AC; Kim CA; Takahashi VN; Passos-Bueno MR; Pereira AC
    Am J Med Genet A; 2014 Nov; 164A(11):2952-7. PubMed ID: 25124994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. K-RasV14I recapitulates Noonan syndrome in mice.
    Hernández-Porras I; Fabbiano S; Schuhmacher AJ; Aicher A; Cañamero M; Cámara JA; Cussó L; Desco M; Heeschen C; Mulero F; Bustelo XR; Guerra C; Barbacid M
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16395-400. PubMed ID: 25359213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noonan and LEOPARD syndrome Shp2 variants induce heart displacement defects in zebrafish.
    Bonetti M; Paardekooper Overman J; Tessadori F; Noël E; Bakkers J; den Hertog J
    Development; 2014 May; 141(9):1961-70. PubMed ID: 24718990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofibromatosis-Noonan Syndrome: A Possible Paradigm of the Combination of Genetic and Epigenetic Factors.
    Yapijakis C; Pachis N; Voumvourakis C
    Adv Exp Med Biol; 2017; 987():151-159. PubMed ID: 28971455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.